Autolus Ltd. has 997 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 25.3%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
As of September 2025
Autolus
workforce metrics
Headcount
997
Avg. Salary
$109k
Tenure
2.0yr
Growth Rate
25.3%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Autolus annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Autolus annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?